Abstract: Variation in the use of VTE prophylaxis was observed between the units, and prophylaxis use was associated with a decrease in the odds of mortality. These findings provide an opportunity to engage with units to further explore differences in prophylaxis use and develop future best practice guidelines.
Introduction
Patients suffering from severe burns enter a "hypercoagulable" state, where systemic inflammation, extensive tissue damage, and prolonged immobility significantly increase the risk of venous thromboembolism (VTE). These clots can lead to fatal pulmonary embolisms. Despite these risks, the burn care community lacks a universal "gold standard" for VTE prophylaxis. Clinicians must often navigate a complex trade-off between preventing clots and managing the risk of bleeding during frequent surgical interventions. This study investigates the extent of practice variation across specialized burn units in Australia and New Zealand and evaluates the impact of prophylaxis on patient survival.
Methods and Datasets
Researchers conducted a retrospective cohort study using data from the Burns Registry of Australia and New Zealand (BRANZ). The study analyzed 5,066 adult admissions (aged ≥16 years) across 17 specialist burn units between July 2016 and December 2018. The final analysis focused on 4,697 patients with valid VTE prophylaxis data.
To account for differences in patient severity across sites, the team employed mixed-effects logistic regression and risk-adjusted funnel plots. These methods allowed for a comparison of hospital performance while adjusting for covariates such as age, gender, burn size (%TBSA), inhalation injury, and ICU admission status.
Key Results
Significant Variation in Practice
The study revealed a striking lack of consensus in clinical practice. While the overall prophylaxis rate was 80.9%, unadjusted rates at individual units ranged from a low of 48.6% to a high of 95.8%. Even after adjusting for patient risk factors, significant outliers remained, suggesting that local hospital culture or individual surgeon preference—rather than patient need alone—drives treatment decisions.
Mortality Benefit
Crucially, the administration of VTE prophylaxis was strongly associated with improved survival. After adjusting for confounders, patients who received prophylaxis had a 79% reduction in the odds of in-hospital mortality compared to those who did not (Adjusted Odds Ratio = 0.21; 95% CI, 0.07–0.63; p = 0.006). While non-fatal VTE events occurred in approximately 3% of the population, the mortality link remained robust.
Discussion and Insights
The data suggests a "selective targeting" approach by clinicians: sicker patients (older, larger burns, inhalation injuries) were more likely to receive anticoagulants. However, the massive swing in rates between units indicates a "postcode lottery" in care.
The authors propose that VTE prophylaxis may serve as a surrogate for overall quality of care; units with rigorous VTE protocols may also excel in other critical care domains. Standardizing these protocols presents a major opportunity to improve outcomes across the region.
Limitations and Future Work
This study is limited by the registry's simple "Yes/No" data for prophylaxis, which lacks detail on drug types, dosages, or timing. Additionally, data on mechanical prophylaxis (e.g., compression stockings) was unavailable. As an observational study, it demonstrates association rather than definitive causation. Future efforts should focus on developing bi-national best-practice guidelines to eliminate unwarranted variation and ensure consistent, evidence-based care for all high-risk burn patients.
Summary updated